Watchlist Price Alert

Zynerba Pharmaceuticals I... (ZYNE)

NASDAQ: ZYNE · Real-Time Price · USD

1.30

0.03 (2.36%)

At close: Oct 10, 2023, 10:00 PM

Zynerba Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-37.58M	-36.66M	-35.04M	-35.83M	-37.74M	-37.84M	-37.31M	-38.11M	-36.58M	-46.96M	-51.34M	-52.43M	-45.33M	-36.13M	-32.94M	-30.02M	-35.88M	-36.75M	-39.91M	-40.24M	-40.74M	-37.06M	-32.01M	-30.79M	-28.46M	-26.37M	-23.39M	-21.93M	-19.94M	-15.34M
Depreciation & Amortization	221.89K	210.23K	219.28K	227.81K	238.52K	246.38K	247.14K	245.03K	240.92K	227.27K	207.03K	182.93K	161.16K	145.84K	133.88K	124.58K	113.6K	102.26K	99.57K	99.04K	98.77K	100.36K	94.21K	90.38K	91.45K	82.16K	75.3K	66.55K	48.94K	38.14K
Stock-Based Compensation	3.65M	3.99M	4.33M	4.35M	4.88M	5.71M	5.81M	6.01M	5.71M	5.12M	5.18M	5.14M	5.25M	5.39M	5.56M	5.95M	6.16M	6.44M	6.63M	6.41M	6.55M	6.15M	5.65M	5.15M	4.24M	3.69M	3.27M	3.15M	2.34M	1.53M
Other Working Capital	1.21M	747.37K	7.39M	7.17M	7.19M	7.04M	-1.48M	4.55K	-2.45M	4.47M	6.78M	5.22M	-333.52K	-4.88M	-7.78M	-9.44M	2.66M	-683.08K	-314.5K	370.33K	9.17K	-1.33M	-1.06M	-699.46K	-1.66M	-929.78K	-1.54M	658.71K	-584.21K	665.27K
Other Non-Cash Items	7.46M	7.46M	7.46M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	99.15K	99.15K	99.15K	99.15K	n/a	836.82K	836.82K
Deferred Income Tax	-7.46M	-7.46M	-7.46M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.38M	-3.1M	-4.46M	-5.65M	-5.05M	-4.14M	-3.6M	-3.17M	-3.15M	-2.34M	-1.53M
Change in Working Capital	2.06M	1.35M	7.46M	6.08M	7.06M	6.92M	-2.21M	-756.4K	-4.6M	3.01M	4.64M	5.32M	-192.09K	-5.7M	-7.57M	-9.62M	117.04K	-1.34M	788.51K	829.98K	4.3M	2.26M	428.79K	811.33K	-2.38M	-922.32K	-493.47K	593.2K	1.07M	391.99K
Operating Cash Flow	-31.64M	-31.11M	-23.03M	-25.18M	-25.56M	-24.96M	-33.46M	-32.61M	-35.23M	-38.61M	-41.31M	-41.79M	-40.11M	-36.3M	-34.82M	-33.56M	-29.49M	-31.56M	-32.4M	-32.9M	-29.8M	-28.55M	-25.84M	-24.64M	-26.41M	-23.41M	-20.44M	-18.13M	-15.65M	-12.55M
Capital Expenditures	-200.45K	-192.05K	-154.1K	-146.71K	-51.61K	-99.18K	-47.57K	-109.66K	-132.05K	-307.11K	-445.31K	-431.56K	-465.61K	-242.98K	-129.39K	-210.3K	-193.7K	-293.9K	-286.66K	-181.69K	-154.72K	-64.12K	-115.36K	-113.97K	-159.3K	-149.71K	-109.63K	-126.97K	-198.57K	-238.59K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-200.45K	-192.05K	-154.1K	-146.71K	-51.61K	-99.18K	-47.57K	-109.66K	-132.05K	-307.11K	-445.31K	-431.56K	-465.61K	-242.98K	-129.39K	-210.3K	-193.7K	-293.9K	-286.66K	-181.69K	-154.72K	-64.12K	-115.36K	-113.97K	-159.3K	-149.71K	-109.63K	-126.97K	-198.57K	-238.59K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	5.32M	6M	6.01M	5.61M	2.32M	1.63M	42.16M	44.05M	44.14M	71.41M	30.85M	28.99M	28.92M	28.88M	45.25M	45.14M	75.23M	48.02M	29.94M	33.01M	2.89M	3.26M	57.5M	59.22M	64.61M	64.25M	10M	5.23M	42.24M	42.22M
Financial Cash Flow	5.32M	6M	6.01M	5.61M	2.32M	1.63M	42.16M	44.05M	44.14M	71.41M	30.85M	28.99M	28.92M	28.88M	45.25M	45.14M	75.23M	48.02M	29.94M	33.01M	2.89M	3.26M	57.5M	59.22M	64.61M	64.25M	10M	5.23M	42.24M	42.22M
Net Cash Flow	-26.52M	-25.3M	-17.17M	-19.71M	-23.29M	-23.43M	8.65M	11.33M	8.77M	32.49M	-10.91M	-13.24M	-11.66M	-7.66M	10.3M	11.37M	45.55M	16.17M	-2.75M	-73.91K	-27.06M	-25.36M	31.54M	34.47M	38.05M	40.68M	-10.55M	-13.03M	26.39M	29.43M
Free Cash Flow	-31.84M	-31.3M	-23.18M	-25.32M	-25.62M	-25.06M	-33.51M	-32.72M	-35.36M	-38.92M	-41.76M	-42.22M	-40.57M	-36.54M	-34.95M	-33.77M	-29.68M	-31.85M	-32.68M	-33.08M	-29.95M	-28.62M	-25.96M	-24.75M	-26.57M	-23.56M	-20.55M	-18.25M	-15.85M	-12.78M